Oracle Corporation (NYSE:ORCL) Shares Sold by ANTIPODES PARTNERS Ltd

ANTIPODES PARTNERS Ltd cut its stake in shares of Oracle Corporation (NYSE:ORCL - Free Report) by 45.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 282,070 shares of the enterprise software provider's stock after selling 235,923 shares during the period. Oracle accounts for about 1.2% of ANTIPODES PARTNERS Ltd's portfolio, making the stock its 27th biggest position. ANTIPODES PARTNERS Ltd's holdings in Oracle were worth $39,439,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also modified their holdings of the stock. Redmont Wealth Advisors LLC bought a new position in shares of Oracle during the first quarter valued at approximately $27,000. Inlight Wealth Management LLC bought a new position in Oracle in the 1st quarter valued at $28,000. Iron Horse Wealth Management LLC increased its stake in Oracle by 284.9% in the first quarter. Iron Horse Wealth Management LLC now owns 204 shares of the enterprise software provider's stock worth $29,000 after purchasing an additional 151 shares during the period. Sunbeam Capital Management LLC bought a new stake in shares of Oracle during the fourth quarter worth $30,000. Finally, Hurley Capital LLC purchased a new stake in shares of Oracle during the fourth quarter valued at $33,000. 42.44% of the stock is owned by institutional investors.

Oracle Price Performance

NYSE ORCL traded up $0.74 during mid-day trading on Thursday, hitting $242.64. The stock had a trading volume of 8,229,157 shares, compared to its average volume of 13,587,158. The firm's 50 day moving average is $202.72 and its 200 day moving average is $171.02. The company has a debt-to-equity ratio of 4.07, a current ratio of 0.75 and a quick ratio of 0.75. The stock has a market capitalization of $681.53 billion, a price-to-earnings ratio of 55.91, a PEG ratio of 3.61 and a beta of 1.39. Oracle Corporation has a twelve month low of $118.86 and a twelve month high of $251.60.

Oracle (NYSE:ORCL - Get Free Report) last announced its quarterly earnings data on Wednesday, June 11th. The enterprise software provider reported $1.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.06. The company had revenue of $15.90 billion during the quarter, compared to analysts' expectations of $15.58 billion. Oracle had a net margin of 21.68% and a return on equity of 87.34%. Oracle's revenue was up 11.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.63 EPS. Equities research analysts forecast that Oracle Corporation will post 5 earnings per share for the current fiscal year.

Oracle Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, July 24th. Shareholders of record on Thursday, July 10th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Thursday, July 10th. This represents a $2.00 annualized dividend and a yield of 0.82%. Oracle's dividend payout ratio (DPR) is 46.08%.

Insider Buying and Selling

In related news, Director Rona Alison Fairhead acquired 480 shares of the stock in a transaction that occurred on Monday, July 7th. The stock was purchased at an average price of $233.87 per share, with a total value of $112,257.60. Following the transaction, the director owned 22,110 shares of the company's stock, valued at approximately $5,170,865.70. This trade represents a 2.22% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Naomi O. Seligman sold 3,303 shares of Oracle stock in a transaction that occurred on Wednesday, July 16th. The shares were sold at an average price of $233.32, for a total transaction of $770,655.96. Following the completion of the sale, the director owned 31,447 shares of the company's stock, valued at $7,337,214.04. This trade represents a 9.51% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 448,669 shares of company stock valued at $85,555,309. 42.20% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several research analysts have issued reports on the stock. Bank of America increased their target price on shares of Oracle from $156.00 to $220.00 and gave the stock a "neutral" rating in a report on Thursday, June 12th. Piper Sandler raised shares of Oracle from a "neutral" rating to an "overweight" rating and upped their price target for the stock from $190.00 to $270.00 in a research report on Thursday, July 10th. Cowen reissued a "buy" rating on shares of Oracle in a report on Thursday, June 12th. Citigroup raised shares of Oracle from a "hold" rating to a "strong-buy" rating in a research note on Friday, July 18th. Finally, Stifel Nicolaus raised Oracle from a "hold" rating to a "buy" rating and increased their target price for the company from $180.00 to $250.00 in a research report on Monday, June 30th. Nine equities research analysts have rated the stock with a hold rating, twenty-three have given a buy rating and three have assigned a strong buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $218.29.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.